More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy Roll, flip, spin: Stanford develops amphibious millirobot for fantastic voyage Oral insulin project identifies spray drying as key to increasing nanoparticle loading In a first, China approves eye implant based solely on real-world data The top 10 most profitable pharma companies in 2021 'The Top Line' podcast: The top 10 list of pharma profits turns up some surprises, bluebird bio's gene therapies win over FDA's expert panel, plus this week's headlines Featured Story | By Nick Paul Taylor Novartis’ Sandoz is pushing to wipe out an advantage AbbVie’s Humira enjoys over its biosimilar rival in the EU, securing regulatory acceptance of a filing for a high-concentration formulation of the autoimmune treatment. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor A Stanford University team has created the amphibious all-terrain vehicle of the drug delivery world. The researchers designed the millimeter-scale robot to roll, flip and spin past obstacles and through liquids to navigate complex biomedical environments. read more By Nick Paul Taylor Producing dry insulin nanoparticles through spray drying may open the door to dosage forms such as oral tablets or bioadhesive films, according to research published in the Nature journal Scientific Reports. read more By Nick Paul Taylor EyePoint Pharmaceuticals’ partner has received Chinese approval for an implant to treat a form of eye inflammation, becoming the first company to get a nod in the country based entirely on real-world data. Ocumension Therapeutics paid an initial $1.75 million to access EyePoint’s technology in 2018. read more By Angus Liu,Eric Sagonowsky,Kevin Dunleavy,Fraiser Kansteiner,Zoey Becker While revenue reflects how well a pharma company’s products and services are selling, profit represents another important measurement that provides investors a look at the health of the business and how efficiently it has been managed. Here, we rank the top 10 pharma companies by 2021 net income. read more By Teresa Carey This week on "The Top Line," we discuss our special report on the top 10 most profitable pharma companies in 2021. We also talk about the two bluebird bio gene therapy candidates that won expert recommendations for FDA approvals. Plus, we're back in person (and on billboards) at BIO. read more Resources Sponsored by: Blue Matter, strategic consultants in the life sciences Medical Affairs plays a critical role in generating insights to inform strategic decisions, but that role is changing. This paper explores why, and how MA teams can stay ahead of the curve. Sponsored by: PwC Don’t miss these critical considerations when evaluating your HCP interactions management program. Sponsored by: Merit Solutions Quality operations guide your organization through regulatory compliance processes and safeguard your products, processes, and reputation. But your team is capable of so much more. Quality incident data and processes can be a driver of significant business value if shared with other stakeholders. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent Orally Inhaled & Nasal Drug Delivery: A Pipeline of Opportunities Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Fierce Health Payer Summit October 12, 2022 | Free Virtual Event Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Drug Development Boot Camp® 2022 November 16-17, 2022 Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Free Virtual Event | 